Abstract:OBJECTIVE:To investigate the origin of oxidative stress induced by angiotensin II (AngII) in human mesangial cells and the role of reactive oxygen species (ROS) in AngII-induced monocyte chemoattractant protein-1 (MCP-1) expression.METHODS:MCP-1 expression was determined by real time RT-PCR. ROS production was measured by DCFDA fluorescence. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity was examined by lucigenin chemiluminescence. p47phox and p67phox translocation was assayed by Western blot. Twenty-four male mice were randomly divided into three groups: the control, the AngIIinfusion [AngII 400 ng/(kg.min)], and the apocynin treatment. AngII was infused by subcutaneously osmotic minipump for 14 days. Urinary albumin and 8-isoprostane excretion were measured by ELISA.RESULTS:In cultured human mesangial cells, AngII induced the MCP-1 expression in a dose-dependent manner with 3.56 fold increase as compared with the control. AngII increased intracellular ROS production as early as 3 min with the peak at 60 min and was in a time and dose-dependent. Incubation with different dosages of AngII (1 nmol/L, 10 nmol/L, and 100 nmol/L AngII) for 60 min, ROS production increased at 1.82, 2.92, and 4.08 folds respectively. AngII-induced ROS generation was sensitive to diphenyleneiodonium sulfate (DPI, 10 micromol/L) and apocynin (500 micromol/L), two structurally distinct NADPH oxidase inhibitors. In contrast, inhibitors of other oxidant-producing enzymes, including the mitochondrial complex Iinhibitor rotenone, the xanthine oxidase inhibitor allopurinol, the cyclooxygenase inhibitor indomethacin, the lipoxygenase inhibitor nordihydroguiaretic acid, the cytochrome P450 oxygenase inhibitor ketoconazole and the nitric oxide synthase inhibitor G-nitro-L-arginine methyl ester were without an effect. AngII-induced ROS generation was inhibited by the AT1 antagonist losartan (10 micromol/L) but not the AT2 antagonist PD123319 (10 micromol/L). AngII treatment induced translocation of cytosolic of p47phox and p67phox to the membrane. The antioxidants almost abolished AngII-induced MCP-1 expression. AngII infusion increased urinary and p67 translocation by 2.69-, 2.97-, and 2.67-fold, respectively.CONCLUSIONS:NADPH oxidase-derived ROS is involved in AngII-induced MCP-1 expression. Inhibition of NADPH oxidase alleviates AngII-induced renal injury.

Role of Angiotensin II Type 1 Receptor in Angiotensin II-Induced Cytokine Production in Macrophages

Angiotensin II Enhances Group 2 Innate Lymphoid Cell Responses Via AT1a During Airway Inflammation.

Angiotensin II Type 2 Receptor Inhibits M1 Polarization and Apoptosis of Alveolar Macrophage and Protects Against Mechanical Ventilation-Induced Lung Injury

Angiotensin II induces the expression of c-reactive protein via MAPK-dependent signal pathway in U937 macrophages.

Anti‐inflammatory Action of Angiotensin‐(1–7) and the Angiotensin Type 2 Receptor Agonist Compound 21 in Hypothalamic Microglia

Role of Reactive Oxygen Species in Angiotensin II: Induced Receptor Activator of Nuclear Factor-Κb Ligand Expression in Mouse Osteoblastic Cells.

Angiotensin II Induces Monocyte Chemoattractant Protein‑1 Expression by Increasing Reactive Oxygen Species‑mediated Activation of the Nuclear Factor‑κb Signaling Pathway in Osteoblasts.

Angiotensin II Induces AT1 Receptor Upregulation by Oxidative Stress and Activation of AP1 and NF‐κB in Two Neuronal Cell Lines

Angiotensin II Induces C-Reactive Protein Expression Via AT1-ROS-MAPK-NF-&#954;B Signal Pathway in Hepatocytes

[NADPH Oxidase-Derived Reactive Oxygen Species Involved in Angiotensin II-induced Monocyte Chemoattractant Protein-1 Expression in Mesangial Cells].

Angiotensin II-induced Egr-1 expression is suppressed by peroxisome proliferator-activated receptor-γ ligand 15d-PGJ₂ in macrophages

[Angiotensin II Induces Expression of Inflammatory Mediators in Vascular Adventitial Fibroblasts].

EXP-2528, a Novel Angiotensin II Type 1 Receptor Antagonist, Protects Angiotensin II-stimulated Intercellular Adhesion Molecule-1 Via Nuclear Factor-Κb Activation in Brain Microvascular Endothelial Cells

Angiotensin II stimulates intercellular adhesion molecule-1 via an AT 1 receptor/nuclear factor-κB pathway in brain microvascular endothelial cells

[Role of AT2 Receptors on Angiotensin II-induced Tumor Necrosis Factor Alpha and Interleukin 1 Beta Secretion in Adult Rat Cardiac Fibroblasts].

Angiotensin Ⅱ type 2 receptors participate in the regulation of inflammatory cytokine secretion in adult rat hypertrophied cardiomyocytes

[Angiotensin II Induces Toll-Like Receptor 4 Expression and Myeloperoxidase Activity in RAW264.7 Cells].

Angiotensin II Induces Inflammatory Response Partly Via Toll-Like Receptor 4-Dependent Signaling Pathway in Vascular Smooth Muscle Cells.

Angiotensin II induces C-reactive protein expression through ERK1/2 and JNK signaling in human aortic endothelial cells.

Angiotensin II-induced Upregulation of AT(1) Receptor Expression: Sequential Activation of NF-kappaB and Elk-1 in Neurons.

Angiotensin II Induces Upregulation of AT1 Receptors Via the Sequential Activation of Transcription Factors NFkB, Elk‐1 and AP‐1 in Cath.a Cells